A PBM audit notice demanding wholesaler invoices is rarely a routine paperwork request. The pharmacy benefit manager compares the pharmacy's dispensing records against its wholesaler purchase history for a defined lookback period, and where the invoices on file do not cover the quantity billed for a given drug, the difference is logged as a shortage. That shortage is then treated less like a bookkeeping gap and more like an unsubstantiated, or even fraudulent, claim. Once the finding is made, the pharmacy is often given a narrow window to produce complete invoice records or accept a recoupment demand calculated on the shortage alone, or extrapolated across the full audit period.
How Invoice Reconciliation Audits Work
The mechanics are consistent across most PBM audits, including those run by Navitus and OptumRx. The auditor selects a set of national drug codes, usually higher-cost or higher-volume products, and pulls every claim the pharmacy billed for those codes over the lookback window, often twelve to twenty-four months. It then requests the pharmacy's corresponding wholesaler purchase invoices for the same period and calculates whether the units purchased are sufficient to cover the units dispensed. Any unit dispensed that cannot be matched to a purchased unit is flagged as a shortage. The audit does not ask whether the drug was actually given to a patient; it asks only whether the paper trail proves it was purchased.
When a Shortage Becomes an Extrapolated Demand
A shortage finding in a small sample of claims rarely stays small. Many PBM audit protocols apply extrapolation, the statistical projection of an error rate found in the sampled claims across every claim billed for that drug during the entire audit period. A shortage on a handful of high-cost prescriptions can be projected into a recoupment demand many times larger than the sampled discrepancy, and an unresolved shortage finding is also one of the fact patterns PBMs cite when moving toward network termination, not merely a dollar recoupment. Understanding whether a given network termination followed an unanswered invoice finding, or a different audit failure, matters for how the pharmacy responds.
An invoice gap is a documentation problem until the pharmacy treats it as a legal one, and by the time extrapolation is applied, the dollar figure on the table has already outgrown the underlying discrepancy.
Building Proof of Purchase
Wholesaler invoices are the primary evidence, but they are rarely the only evidence available to close a shortage. Legitimate explanations for a purchase-to-dispense variance include manufacturer samples, product returns and credits, transfers between store locations, shrinkage, and prescriptions that were adjudicated but never picked up. A pharmacy should also request its own purchase history directly from the wholesaler rather than relying only on what the PBM's auditor already pulled, particularly where a distributor relationship has since ended and older records are harder to retrieve. Reconstructing the purchase record before it is needed, not after an audit notice arrives, is the most reliable way to avoid an unexplained gap becoming a recoupment. Where the PBM's own audit and audit appeal procedures allow substitute documentation, such as wholesaler statements, delivery receipts, or perpetual inventory reports, those records should be gathered and submitted within the appeal window rather than after it closes. Many states have also enacted fair-audit statutes that limit how a PBM may treat a documentation gap, including restrictions on recouping for clerical or recordkeeping errors and on relying on extrapolation rather than the actual variance; whether and how those protections apply is state-specific and worth confirming with counsel before the appeal is filed.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain experienced healthcare defense counsel upon receiving a PBM invoice audit notice or shortage finding. Early legal intervention can protect the pharmacy's rights, ensure the invoice reconciliation is presented correctly and completely, avoid inadvertent admissions, and preserve appeal rights before recoupment or network termination follows. Delaying legal representation can significantly affect the outcome of a matter and expose the pharmacy to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance has represented 2,500+ clients over 25+ years in matters involving PBM invoice reconciliation, shortage findings, and extrapolated recoupment demands. Our PBM audit defense attorneys help pharmacies assemble complete purchase records, challenge extrapolation, and pursue the audit appeal before recoupment or termination is finalized. Contact Health Law Alliance for a free, confidential consultation.
